Efficacy of edaravone, a free radical scavenger, on left ventricular function and structure in diabetes mellitus

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 6, 2003, Pages 923-929

  Hayashi, Tetsuya ^a   Mori, Tatsuhiko ^a   Sohmiya, Koichi ^a   Okada, Yoshikatsu ^a   Inamoto, Sakiko ^a   Okuda, Nobuaki ^a   Mori, Hiroshi ^a   Kitaura, Yasushi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Cardiac function; Diabetes mellitus; Immunohistochemistry; Oxidative stress; Ultrastructure

Indexed keywords

GLUCOSE; NORPHENAZONE; SCAVENGER; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEMODYNAMICS; HYPERGLYCEMIA; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RAT STRAIN;

ANIMALS; ANTIOXIDANTS; ANTIPYRINE; BLOOD GLUCOSE; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 2; FREE RADICAL SCAVENGERS; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, ELECTRON; MICROSCOPY, POLARIZATION; MYOCARDIUM; NADP; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, INBRED OLETF; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VENTRICULAR FUNCTION, LEFT;

EID: 0037780692     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200306000-00014     Document Type: Article

References (24)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.
2. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care. 1996;19:257-67.
3. Shinomiya K, Fukunaga M, Kiyomoto H, et al. A role ofoxidative stress-generated eicosanoid in the progression of arteriosclerosis in type 2 diabetes mellitus model rats. Hypertens Res. 2002;25:91-8.
4. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067-72.
5. Abou-Seif MA, Youssef AA. Oxidative stress and male IGF-1, gonadotropin and related hormones in diabetic patients. Clin Chem Lab Med. 2001;39:618-23.
6. Foresti R, Clark JE, Green CJ, et al. Thiol compounds interact with nitric oxide in regulating heme oxygenase-1 induction in endothelial cells: involvement of superoxide and peroxynitrite anions. J Biol Chem. 1997;272:18411-7.
7. Ishizaka N, Aizawa T, Mori I., et al. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol. 2000;279:H672-8.
8. Watanabe T, Yuki S, Egawa M, et al. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther. 1993;268:1597-604.
9. Watanabe T, Morita I, Nishi H, et al. Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukot Essent Fatty Acids. 1988;33:81-7.
10. Yanagisawa A, Miyagawa M, Ishikawa K, et al. Cardioprotective effect of MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) during acute ischemia-reperfusion injury in rats. Int J Angiol. 1994;3:12-5.
11. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke. 1998;19:480-5.
12. Awano H, Soejima J, Inoue H. Physical dependence study on MCI-186 in rats. Jpn Pharmacol Ther. 1997;25(suppl):161-2. Abstract.
13. Kawano K, Hirashima T, Mori S, et al. Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes. 1992;41:1422-8.
14. Yagi K, Kim S, Wanibuchi H, et al. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension. 1997;29:728-35.
15. Hayashi T, Sohmiya K, Ukimura A, et al. Improvement of left ventricular diastolic dysfunction by the treatment of angiotensin receptor blockade in OLETF diabetic rats. Eur Heart J. 2001;22(suppl):412. Abstract.
16. Hayashi T, James TN, Buckingham DC. Ultrastructure and immunohistochemistry of the coronary chemoreceptor in human and canine hearts. Am Heart J. 1995;129:946-59.
17. Hayashi T, Imamura K, Kawamura, et al. Quantitative ultrastructural study of the myocardium in experimental cardiac hypertrophy. J Clin Electron Microscopy. 1985;18:449-50.
18. Hayashi T, Ijiri Y, Toko H, et al. Increased digitalis-like immunoreactive substances in patients with hypertrophic cardiomyopathy. Eur Heart J. 2000;21:296-305.
19. Wallace MN. NADPH diaphorase activity in activated astrocytes representing inducible nitric oxide synthase. Methods Enzymol. 1996;268:497-503.
20. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
21. Yamada T, Moralejo DH, Wei S, et al. Genomic background of the OLETF rat. In: Shima K (ed). Obesity and NIDDM: lessons from the OLETF rat. Amsterdam, Tokyo: Elsevier, 1999:13-26.
22. Mizushige K, Yao L, Noma T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation. 2000;101:899-907.
23. Kojda G, Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res. 1999;15:562-71.
24. 2+ signaling and cardiac apoptosis. Biol Signals Recept. 2001;10:200-23.